PENNSYLVANIA STATE UNIVERSITY

Pennsylvania State University specializes in pre-clinical research and development in biotechnology, with a focused expertise in modeling infectious diseases for public health applications. Their work involves the design, validation, and deployment of in vitro and in vivo systems that simulate human pathogen responses, enabling the evaluation of therapeutics, vaccines, and diagnostic tools prior to clinical trials. Technical capabilities include animal model development, pathogen characterization, immunological assay validation, and biosafety level containment protocols, all aligned with FDA and CDC pre-clinical standards. The university’s unique differentiator lies in its integration of academic rigor with translational research pipelines, bridging laboratory discovery with actionable public health outcomes. The contractor has demonstrated direct engagement with the Department of Health and Human Services, delivering mission-critical research services under task areas related to infectious disease modeling. This relationship reflects a consistent alignment with HHS’s strategic priorities in pandemic preparedness, emerging pathogen response, and biomedical innovation. The work is typically conducted through research contracts supporting agencies such as NIH and CDC, emphasizing peer-reviewed methodologies and reproducible experimental design. The primary industry focus is on NAICS 541714—research and development in biotechnology—where the contractor advances non-nanobiotechnology applications in infectious disease biology. This includes host-pathogen interaction studies, biomarker identification, and pre-clinical efficacy testing, positioning the institution as a trusted academic partner in federal biodefense and health security initiatives. As a higher education institution structured as a 2A entity, Pennsylvania State University operates with the scale and infrastructure of a major research university, leveraging federal funding to sustain long-term scientific programs. While no specific government certifications are held, its institutional credibility, IRB and IACUC compliance, and adherence to federal research regulations underpin its role as a reliable contractor in the federal biotech research ecosystem. Its primary presence is in Hershey, PA, with research reach extending nationally through collaborative federal partnerships.